Don’t miss this important live GHAPP Zoom session on September 15, 2025, with Robin Soto, MSN, RN, FNP-BC, as she breaks down the evolving landscape of steatotic liver disease—specifically the clinical distinctions between MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) and MetALD (Metabolic Dysfunction-Associated Alcohol-Related Liver Disease).

As the terminology and diagnostic criteria continue to shift from NAFLD (Non-Alcoholic Fatty Liver Disease) to MASLD and MetALD, it’s essential for Advanced Practice Providers (APPs) to understand how these updates affect clinical decision-making, screening protocols, and patient management.

In this focused and practical session, Robin Soto will cover:

• Key differences between MASLD and MetALD

• Updated diagnostic frameworks and risk factors

• How to assess for alcohol use and metabolic syndrome in steatotic liver disease

• Patient-centered communication tips for lifestyle intervention and education

• When to refer for specialty care or advanced liver imaging

• Strategies to reduce liver-related complications through early detection

Whether you practice in gastroenterology, hepatology, or primary care, this session will provide clinically relevant insights and evidence-based tools to enhance your approach to patients with suspected or confirmed liver disease.

Event Details:
📅 Date: September 15, 2025
🕐 Time: [Insert Time]
📍 Live via Zoom (link provided after registration)

Join GHAPP and Robin Soto for this timely discussion and earn valuable insights into managing one of the most prevalent chronic liver conditions in the U.S.